@ShahidNShah
FDA’s support of AI in telemedicine
Epstein Becker & Green’s Bradley Merrill Thompson describes the agency’s current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI. Many appreciate that telemedicine is more than just using Skype so that a doctor can look a patient in the eyes. For telemedicine to be truly useful, the patient must be able to collect and transmit a variety of data the healthcare professional needs in order to assess the patient’s health. Indeed, state regulators have historically been skeptical of telemedicine precisely because they fear that the doctor-patient relationship in that context is too thin, with doctors being forced to make judgments based on too little available information.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Brigham & Women’s Digital Innovation Hub Spins Up COVID Pass for Employee Screening
- Medicare authorizing telehealth coverage, relaxing rules during coronavirus emergency
- Health system pieces together ‘virtual rounding’ to cope with pandemic
- List of Free COVID-19 Health IT Products and Services
- Life after COVID-19: What Will Change?
Next Article
-
Brigham & Women’s Digital Innovation Hub Spins Up COVID Pass for Employee Screening
Health systems with innovation centers are finding out their value as teams rapidly spin up digital solutions to COVID-19 challenges. One example is the Digital Innovation Hub at Brigham and Women’s …
Posted Apr 27, 2020covid-19